Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004011 · ClinicalTrials.gov registry record · Phase 3
S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
A Phase 3 study of Lung Cancer, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 354
- Enrollment target
- 20
- Study locations
NCT00004011 is a Phase 3 study of Lung Cancer that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 354 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (62% lower). The trial reports 20 study locations across 3 states.
The verdict
NCT00004011, a Phase 3 study of Lung Cancer, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 354 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if surgery plus combination chemotherapy is more effective than surgery alone for non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery with or without combination chemotherapy in treating patients who have non-small cell lung cancer.
Conditions Studied
Interventions
- DRUG carboplatin
- DRUG paclitaxel
- PROCEDURE conventional surgery
Study Locations (20)
California
- Providence Saint Joseph Medical Center - Burbank - Burbank
- Mount Diablo Medical Center - Concord
- California Cancer Center - Fresno
- Saint Agnes Cancer Center - Fresno
- Sutter Health Western Division Cancer Research Group - Greenbrae
- Loma Linda University Cancer Institute at Loma Linda University Medical Center - Loma Linda
- Veterans Affairs Medical Center - Long Beach - Long Beach
- USC/Norris Comprehensive Cancer Center and Hospital - Los Angeles
- Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
- CCOP - Bay Area Tumor Institute - Oakland
- Huntington Cancer Center at Huntington Hospital - Pasadena
Alabama
- University of Alabama at Birmingham Comprehensive Cancer Center - Birmingham
- Comprehensive Cancer Institute - Huntsville
- Huntsville Hospital - Huntsville
- MBCCOP - Gulf Coast - Mobile
- Montgomery Cancer Center - Montgomery
- DCH Cancer Treatment Center - Tuscaloosa
- Radiation Oncology Associates of West Alabama - Tuscaloosa
Arizona
- Foundation for Cancer Research and Education - Phoenix
- CCOP - Mayo Clinic Scottsdale Oncology Program - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 1999-10 |
| Est. Completion | 2012-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004011
The ClinicalTrials.gov registry entry for NCT00004011 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 354 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (62% lower). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which carboplatin is the first listed.
NCT00004011 reports 20 study locations spanning 3 distinct geographic areas - top geographies include California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00004011 about?
NCT00004011 is a clinical study titled "S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if surgery plus combination chemotherapy is more effective than surgery alone for non-small cell lung ca...
What is the current status of trial NCT00004011?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 354 participants. The study started on 1999-10. Estimated completion is 2012-11.
What conditions does trial NCT00004011 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00004011?
The interventions under investigation include: carboplatin (DRUG), paclitaxel (DRUG), conventional surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00004011?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004011 being conducted?
This trial has 20 study locations across Alabama, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
RECRUITING · Phase 3
-
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
RECRUITING · Phase 3
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RECRUITING · Phase 3
-
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
ACTIVE NOT RECRUITING · Phase 3
-
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
COMPLETED · Phase 3
-
Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.